GUTS fractyl.com Net earnings per share for the last 12 months

Public company logo of Fractyl Health, Inc. (GUTS)

Fractyl Health, Inc. (GUTS) is developing medical logistics to ensure the rapid delivery of therapy systems to clinics. The change in rolling net income per share visualizes the financial dynamics, where the -5.72 parameter determines the metric's magnitude. Fractyl Health, Inc. (GUTS) is implementing the Revita method for the natural restoration of metabolism in type 2 diabetes. However, high R&D costs and dependence on test results necessitate strict liquidity control.

GUTS (Fractyl Health, Inc) Net earnings per share (EPS TTM) history from 02/21/2024 to 11/15/2026

Analytical breakdowns and data insights for company Fractyl Health, Inc (GUTS)

- stock price and consensus target price:
Stock Price Fractyl Health, Inc|GUTS - Average Forecast Price
- market capitalization data:
Market Valuation Fractyl Health, Inc.|GUTS - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Fractyl Health|GUTS - Book Capitalization|Market Capitalization to Book Value Ratio fractyl.com|GUTS - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Fractyl Health, Inc.|GUTS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Fractyl Health, Inc.|GUTS - Company Debts|Debts to Book Capitalization Fractyl Health|GUTS - Long-Term Debt Volume|Company Short-Term Debt Fractyl Health|Quick Liquidity fractyl.com
- net income and valuation multiples indicators:
GUTS - Net Income|Projected Future Earnings Fractyl Health, Inc.|GUTS - Market Cap to Net Income|Future Price to Earnings Fractyl|GUTS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Fractyl Health Inc.|GUTS - Operating profit EBITDA|Net earnings per share (EPS TTM) Fractyl Health|GUTS - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months fractyl.com|GUTS - Net earnings per one share growth for the current year|Expected earnings per share growth for next year Fractyl Health, Inc.
- sales and revenue data:
GUTS - Company Total Revenue|Company Projected Revenue Fractyl Health|GUTS - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Fractyl Health, Inc
Fundamental company valuation:Fractyl Health Inc. (GUTS)
Mass-produced product of Fractyl

Fractyl Health, Inc. (GUTS) develops innovative endoscopic systems for diabetes therapy, establishing a market for long-term consumable supplies. Earnings per share (EPS TTM) measures the portion of total income attributable to a single security over one year. This metric allows for an assessment of real capital management efficiency and the risk of overpaying for the asset. It is critical for investors to align the monetization rates of medical technologies with financial returns. An analysis of the annual earnings per share trend confirms the resilience of the business model.

Competitors of Fractyl Health, Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|Biomea Fusion Inc (BMEA) - Earnings per share for the last twelve months|QNCX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS